MedTrace Logo

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma

NCT03574805 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2020-12-24

No results posted yet for this study

Summary

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects with Mild Asthma

Conditions

Interventions

DRUG

PRS-060

Study drug

DRUG

Placebo

Inhalant designed to mimic PRS-060

Sponsors & Collaborators

  • Pieris Australia Pty Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-26
Primary Completion
2020-09-15
Completion
2020-09-15

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03574805 on ClinicalTrials.gov